Article

Targeted mutation detection in breast cancer using MammaSeq™

2018-02-13

Abstract excerpt

<h4>Background</h4> Breast cancer is the most common invasive cancer among women worldwide. Next-generation sequencing (NGS) has revolutionized the study of cancer across research labs around the globe, however genomic testing in clinical settings remain limited. Advances in sequencing reliability, pipeline analysis, accumulation of relevant data, and the reduction of costs are rapidly increasing the feasibility...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5d777fae-f3e2-56a5-9469-b38ae76d7bf9
DOI: 10.1101/264267

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Targeted mutation detection in breast cancer using MammaSeq™DOI 10.1101/264267Read

Targeted mutation detection in breast cancer using MammaSeq™Semantic proximity Read

Detection of genomic alterations in breast cancer with circulating tumour DNA sequencingSemantic proximity Read

Detection of genomic alterations in breast cancer with circulating tumour DNA sequencing.Semantic proximity Read

Targeted deep sequencing revealed variants in cell-free DNA of hormone receptor-positive metastatic breast cancer patientsSemantic proximity Read

The validation and clinical implementation of BRCAplus: a comprehensive high-risk breast cancer diagnostic assay.Semantic proximity Read

Validation of a next-generation sequencing assay for clinical molecular oncology.Semantic proximity Read

Identifying Genomic Alterations in Stage IV Breast Cancer Patients using MammaSeq™: An International Collaborative StudySemantic proximity Read

Detection of activating mutations in liquid biopsy of Egyptian breast cancer patients using targeted next-generation sequencing: a pilot study.Semantic proximity Read

Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy.Semantic proximity Read

Machine learning-based somatic variant calling in cell-free DNA of metastatic breast cancer patients using large NGS panelsSemantic proximity Read

Targeted next-generation sequencing detects a high frequency of potentially actionable mutations in metastatic breast cancers.Semantic proximity Read

Next-generation sequencing in breast cancer: current clinical applications and future directionsSemantic proximity Read